AAAAAA

   
Results: 1-8 |
Results: 8
USE OF A DISABLED INFECTIOUS SINGLE-CYCLE (DISC) HERPES-SIMPLEX VIRUS(HSV) AS A VECTOR FOR THE INDUCTION OF IMMUNE-RESPONSES TO PRODUCTS OF HETEROLOGOUS GENES
Authors: HILL S HOLMES CL SHIELDS JG MCLEAN CS ENTWISLE C BLAKELEY D BOURSNELL MEG HICKLING JK
Citation: S. Hill et al., USE OF A DISABLED INFECTIOUS SINGLE-CYCLE (DISC) HERPES-SIMPLEX VIRUS(HSV) AS A VECTOR FOR THE INDUCTION OF IMMUNE-RESPONSES TO PRODUCTS OF HETEROLOGOUS GENES, Journal of leukocyte biology, 1998, pp. 14-14
GENERATION OF A PRIMARY IMMUNE-RESPONSE TO A GENETICALLY INACTIVATED (DISC) HERPES-SIMPLEX VIRUS AND WILD-TYPE VIRUS
Authors: HILL S ZHANG XL BOURSNELL MEG SHIELDS JG RICCIARDICASTAGNOLI P HICKLING JK
Citation: S. Hill et al., GENERATION OF A PRIMARY IMMUNE-RESPONSE TO A GENETICALLY INACTIVATED (DISC) HERPES-SIMPLEX VIRUS AND WILD-TYPE VIRUS, Biochemical Society transactions, 25(2), 1997, pp. 200-200
HERPES VIRUS-SPECIFIC IMMUNE-RESPONSES IN INDIVIDUALS EXPERIENCING RECURRENT GENITAL HERPES
Authors: BOSWELL CM DUNCAN IA UTTRIDGE J SONNEX C HICKLING JK
Citation: Cm. Boswell et al., HERPES VIRUS-SPECIFIC IMMUNE-RESPONSES IN INDIVIDUALS EXPERIENCING RECURRENT GENITAL HERPES, Biochemical Society transactions, 25(2), 1997, pp. 278-278
CONSTRUCTION AND CHARACTERIZATION OF A RECOMBINANT VACCINIA WAS EXPRESSING HUMAN PAPILLOMAVIRUS PROTEINS FOR IMMUNOTHERAPY OF CERVICAL-CANCER
Authors: BOURSNELL MEG RUTHERFORD E HICKLING JK ROLLINSON EA MUNRO AJ ROLLEY N MCLEAN CS BORYSIEWICZ LK VOUSDEN K INGLIS SC
Citation: Meg. Boursnell et al., CONSTRUCTION AND CHARACTERIZATION OF A RECOMBINANT VACCINIA WAS EXPRESSING HUMAN PAPILLOMAVIRUS PROTEINS FOR IMMUNOTHERAPY OF CERVICAL-CANCER, Vaccine, 14(16), 1996, pp. 1485-1494
A RECOMBINANT VACCINIA VIRUS ENCODING HUMAN PAPILLOMAVIRUS TYPE-16 AND TYPE-18, E6 AND E7 PROTEINS AS IMMUNOTHERAPY FOR CERVICAL-CANCER
Authors: BORYSIEWICZ LK FIANDER A NIMAKO M MAN S WILKINSON GWG WESTMORELAND D EVANS AS ADAMS M STACEY SN BOURSNELL MEG RUTHERFORD E HICKLING JK INGLIS SC
Citation: Lk. Borysiewicz et al., A RECOMBINANT VACCINIA VIRUS ENCODING HUMAN PAPILLOMAVIRUS TYPE-16 AND TYPE-18, E6 AND E7 PROTEINS AS IMMUNOTHERAPY FOR CERVICAL-CANCER, Lancet, 347(9014), 1996, pp. 1523-1527
GENERATION OF A PRIMARY IMMUNE-RESPONSE TO A GENETICALLY INACTIVATED (DISC) HERPES-SIMPLEX VIRUS AND WILD-TYPE VIRUS
Authors: HILL S ZHANG X BOURSNELL MEG SHIELDS JG HICKLING JK
Citation: S. Hill et al., GENERATION OF A PRIMARY IMMUNE-RESPONSE TO A GENETICALLY INACTIVATED (DISC) HERPES-SIMPLEX VIRUS AND WILD-TYPE VIRUS, Immunology, 89, 1996, pp. 90-90
HERPES VIRUS-SPECIFIC IMMUNE-RESPONSES IN INDIVIDUALS EXPERIENCING RECURRENT GENITAL HERPES
Authors: BOSWELL CM DUNCAN IA UTTRIDGE J SONNEX C HICKLING JK
Citation: Cm. Boswell et al., HERPES VIRUS-SPECIFIC IMMUNE-RESPONSES IN INDIVIDUALS EXPERIENCING RECURRENT GENITAL HERPES, Immunology, 89, 1996, pp. 235-235
CONSTRUCTION OF A RECOMBINANT VACCINIA VIRUS EXPRESSING HPV TYPES-16 AND TYPE-18, TYPE-EL AND TYPE-E7 FOR IMMUNOTHERAPY OF CERVICAL-CARCINOMA
Authors: HICKLING JK BOURSNELL MEG RUTHERFORD E ROLLINSON E MCLEAN CS STACEY S BORYSIEWICZ LK INGLIS SC
Citation: Jk. Hickling et al., CONSTRUCTION OF A RECOMBINANT VACCINIA VIRUS EXPRESSING HPV TYPES-16 AND TYPE-18, TYPE-EL AND TYPE-E7 FOR IMMUNOTHERAPY OF CERVICAL-CARCINOMA, Journal of cellular biochemistry, 1995, pp. 311-311
Risultati: 1-8 |